Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 1000 patients treated with the DETOUR™ System.

See Release

All News

Archives

Endologix Receives Australian Therapeutic Goods Administration (TGA) Approval for AFX®2 Bifurcated Endograft System

Positive Two-Year Data from the Nellix® EVAS FORWARD Global Registry Presented at 2016 VEITH Symposium

Positive Five-Year Results from the Global Ovation® Pivotal Trial Presented at 2016 VEITH Symposium

Endologix Provides Update on Nellix PMA Process

Endologix Appoints Matthew Thompson, M.D., as Chief Medical Officer